Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Phase Distribution

Ph phase_4

25%

Ph phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

2(66.7%)

Phase 4Post-market surveillance

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(2)

Detailed Status

Completed2

Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (66.7%)

Phase 41 (33.3%)

Trials by Status

completed250%

withdrawn250%

Recent Activity

0 active trials

Showing 4 of 4

withdrawnphase_4

Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer

NCT04487912

completedphase_1

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

NCT02683421

completed

Sentinel Lymph Node Mapping Post-Injection Site Pain

NCT02065232

withdrawnphase_1

Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)

NCT03241446

Clinical Trials (4)

Showing 4 of 4 trials

NCT04487912Phase 4

Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer

Withdrawn

NCT02683421Phase 1

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

Completed

NCT02065232

Sentinel Lymph Node Mapping Post-Injection Site Pain

Completed

NCT03241446Phase 1

Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4